These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 476504)

  • 1. Immunological and biological activities of fragments and analogs of bradykinin.
    Redman LW; Regoli D; Tustanoff ER
    Can J Biochem; 1979 Jun; 57(6):529-39. PubMed ID: 476504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin antibodies: new developments.
    Hilgenfeldt U; Linke R; König W
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S17-9. PubMed ID: 1697355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
    Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
    Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of bradykinin in mammalian brain.
    Perry DC; Snyder SH
    J Neurochem; 1984 Oct; 43(4):1072-80. PubMed ID: 6470707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and molecular characterization of a biotinylated analog of [Lys]bradykinin.
    Sawutz DG; Yanni J; Kelley M; Wolfe H
    Peptides; 1991; 12(5):1019-24. PubMed ID: 1666181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypic antibodies bearing the internal image of a bradykinin epitope. Production, characterization, and interaction with the kinin receptor.
    Haasemann M; Buschko J; Faussner A; Roscher AA; Hoebeke J; Burch RM; Müller-Esterl W
    J Immunol; 1991 Dec; 147(11):3882-92. PubMed ID: 1719093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational and biological properties of Bauhinia bauhinioides kallikrein inhibitor fragments with bradykinin-like activities.
    Alves FL; Oliva ML; Miranda A
    J Pept Sci; 2015 Jun; 21(6):495-500. PubMed ID: 25902925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and properties of new bradykinin potentiating peptides.
    Tominaga M; Stewart JM
    J Med Chem; 1975 Feb; 18(2):130-3. PubMed ID: 1120978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    Liebmann C; Bossé R; Escher E
    Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of bradykinin in blood by a sensitive radioimmunoassay.
    Hulthén UL; Borge T
    Scand J Clin Lab Invest; 1976 Dec; 36(8):833-9. PubMed ID: 1031495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine.
    Reissmann S; Schwuchow C; Seyfarth L; Pineda De Castro LF; Liebmann C; Paegelow I; Werner H; Stewart JM
    J Med Chem; 1996 Feb; 39(4):929-36. PubMed ID: 8632416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
    Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF
    J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
    Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
    J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
    Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin competitive antagonists for classical kinin systems.
    Stewart JM; Vavrek RJ
    Adv Exp Med Biol; 1986; 198 Pt A():537-42. PubMed ID: 3812091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a radioimmunoassay for [DES-ARG9]-bradykinin.
    Odya CE; Moreland P; Stewart JM; Barabe J; Regoli DC
    Biochem Pharmacol; 1983 Jan; 32(2):337-42. PubMed ID: 6870961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two bradykinin binding sites with picomolar affinities.
    Manning DC; Vavrek R; Stewart JM; Snyder SH
    J Pharmacol Exp Ther; 1986 May; 237(2):504-12. PubMed ID: 2871174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational features of bradykinin. A circular dichroism study of some peptide fragments and structural analogues of bradykinin.
    Lintner K; Fermandjian S; Regoli D
    Biochimie; 1979; 61(1):87-92. PubMed ID: 35240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
    Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic antibodies against the kinin receptor.
    Haasemann M; Buschko J; Faussner A; Roscher AA; Hoebeke J; Burch R; Müller-Esterl W
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S47-54. PubMed ID: 1282630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.